Study S002584

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02941445
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 24
Start: 2015-10
Primary completion: 2016-08
Lead sponsor: University Medical Centre Ljubljana
Conditions: Polycystic Ovary Syndrome; Body Weight
Interventions: DRUG:sitagliptin and metformin; DRUG:Metformin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in body weight. [Patient's body weight was measured at the baseline and after 12 weeks of clinical trial.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.